home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  March 19, 2018
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 581 active entries

Celprogen Inc.

3914 Del Amo Blvd, Suite 901
Torrance CA 90503
United States of America, California

Phone: 1 310 542 8822
Fax: 1 310 542 8028


CELPROGEN is a Biopharmaceutical company that has 4 major areas of expertise and market share, Life-sciences, Therapeutics, Cosmetics and Medical device. The therapeutics drug discovery focus is to develop novel pahrmaceutical agents and stem cell therapy for the following disorders cardiovascular, diabetes,cancer, neurological,Renal and metabolic disoders. The life science division provides research reagents and tools for the life science industry with the following products: stem cells, cancer stem cells, tissue culture differentiation and expansion growth medium, proteomic and genomic reagents. The device division of Celprogen provides novel ELISA based assays, protein arrays, DNA arrays, tissue and cell based assays & arrays. Please visit our web site at www.celprogen.com to learn more about our products and services. Stem cell Kits for differentiation, expansion, and maintaining stem cells in their undifferentiated state including iPCs. Primary cell tissue culture kits for cell based cytotoxicity assays and drug discovery assays. Human Cancer Stem Cell kits. Cosmetic division generates regenerative products for hair growth and facial skin regeneration.

Selected Categories:

Product Company   Service Company
- Research
- Research
- Immunoassay
- Research
- Laboratory
- Research
- Research

Last update of this entry: September 27, 2016

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.